Detail akcie Eocene Ltd online

Business Summary: EoCene Ltd., formerly Galmed Pharmaceuticals Ltd., is an Israel-based healthcare technology and biopharmaceutical company engaged in the development of therapeutic products, medical devices, and healthcare technologies. The Company focuses on gastrointestinal diseases, gastrointestinal oncology, and related medical conditions through a portfolio of pharmaceutical and medical device programs. Its activities include research, development, clinical evaluation, and commercialization of therapeutic candidates and medical technologies. The Company’s portfolio includes Aramchol, a therapeutic candidate for liver and oncology-related indications, and medical device technologies developed through its subsidiary Colospan Ltd. for gastrointestinal and colorectal applications. EoCene Ltd. conducts its operations through biopharmaceutical, medical device, and healthcare technology activities.
Financial Summary: BRIEF: For the six months ended 30 June 2026, Eocene Ltd revenues was not reported. Net loss increased 29% to $4.6M. Higher net loss reflects Research and development expenses increase of 86% to $3.1M (expense), Financial expenses, net decrease of 4% to $288K (income). Basic Earnings per Share excluding Extraordinary Items increased from -$10.01813 to -$5.17795.